Longevity and vitality begin deep in cells. MitoQ is a research-backed cell health company that created the world’s first mitochondria-targeted antioxidant. Their patented molecule, MitoQ® Mitoquinol Mesylate, penetrates deep into the mitochondria to reduce free radicals and improve their function. Backed by 25+ clinical trials and adopted globally, MitoQ helps support sharper focus, faster recovery, heart health, and long-term vitality.
Doctor-trusted, effective treatment plans centered around men’s unique needs, especially erectile dysfunction, on terms that are most important to him.
Women’s health, especially their hormones, can play a role in their overall oral health. Smile Generation has ways to make sure women are prioritizing the Mouth-Body-Connection.
Geographic Atrophy (GA), the advanced form of dry age-related macular degeneration (AMD), can irreversibly damage your eyes faster than you may think. When GA progresses, patches of damaged cells called “lesions” grow and can damage parts of your eye that help you read, drive, and recognize faces. SYFOVRE is the only FDA-approved GA treatment proven to slow GA lesion progression in as few as 6 treatments per year.* It’s important to know that GA cannot be stopped or reversed, but slowing GA lesion progression can help slow the damage it causes. SYFOVRE slows GA. Talk to your eye doctor about SYFOVRE today. *Administered by your doctor once every 25-60 days. INDICATION AND IMPORTANT SAFETY INFORMATION What is SYFOVRE®? SYFOVRE® (pegcetacoplan injection) is a prescription eye injection, used to treat geographic atrophy (GA), the dry advanced form of age-related macular degeneration (AMD). Who should NOT receive SYFOVRE? Do not receive SYFOVRE if you have an infection or active swelling in or around your eye that may include pain and redness, or are allergic to pegcetacoplan or any ingredients in SYFOVRE. SYFOVRE can cause serious allergic reactions such as trouble breathing, tongue, face, lips, or mouth swelling, rashes, and hives. SYFOVRE can cause
